Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT06737679
Recruiting Not applicable

The Effects of Body Scan on Enteroception in Patients With Heart Failure

NCT06737679 · tracked via the Priya Life Science Italy tracker
Sponsor
Centro Cardiologico Monzino
Phase
Not applicable
Started
2025-01-28
Last updated
2025-02-07

Condition(s) studied

Heart Failure

Investigational drug(s) / intervention(s)

Body Scan

Body Scan: Body scan is a guided meditation technique that allows people to detect signs and signals from their body (for instance, heart rate). The intervention will last 20 minutes and will be performed 21 consecutives days. The first and last days it will be performed in presence, while the other ones online.

Study summary

The study aims to explore the effects of body scan on enteroception in people with heart failure

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with Heart Failure * Italian speaking * Willing to sign the Informed Consent Form Exclusion Criteria: * Cognitive Impairment documented in the medical records

Primary outcome measure(s)

  • Enteroceptive sensibility — At 1 month after the end of the body scan intervention
    Enteroceptive Sensibility (assessed with the Multidimensional Assessment of Interoceptive Awareness, version 2, MAIA-2) The MAIA-2 is a 6-point Likert scale questionnaire with 37 items divided into 8 subscales. Higher scores reflect greater enteroceptive sensibility.

Trial sites (2)

FacilityCityRegionStatus
Cardiology Center Monzino IRCCS Milan Italy Recruiting
IRCCS Cardiology Center Monzino Milan Italy Not Yet Recruiting

More Centro Cardiologico Monzino trials in Italy

Natural History of Atrial Fibrillation-Induced Tricuspid Valve Remodeling in the Absence of Significant Tricuspid Regurgitation: A Three-Dimensional Echocardiographic Study Recruiting
Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse Recruiting
MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac Amyloidosis Recruiting
Incidence of Late Haemorrhage After Invasive Gastroenterological Endoscopic Manoeuvre in Patients Treated With Anticoagulants Compared to Non-anticoagulated Patients Recruiting
Transcatheter Mitral and Tricuspid Interventions: a Cardiac Magnetic Resonance Study Recruiting

Other trials for the same condition

CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine Recruiting
Personalized Therapy Study - HFRS (TriageHF) Post Approval Study Active, not recruiting
Personalized Therapy Study - Attain Stability Quad Post-Approval Study Active, not recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin Recruiting
Heart Failure and Aortic Stenosis Transcriptome Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06737679 on ClinicalTrials.gov ↗ ← All trials in Italy